Plasma 1,25-dihydroxyvitamin D levels in primary hyperparathyroidism depend on sex, body mass index, plasma phosphate and renal function

Clinical Endocrinology

Volumn 66, Issue 1, 2007, Pages 35-42

  Moosgaard, B ^a   Vestergaard, P ^a   Heickendorff, L ^a   Mosekilde, L ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CALCIUM; PHOSPHATE;

ADULT; AGED; ARTICLE; BODY MASS; BONE DENSITY; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FRACTURE; HUMAN; HYPERCALCEMIA; HYPOPHOSPHATEMIA; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NEPHROLITHIASIS; PHOSPHATE BLOOD LEVEL; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; SEX; UNIVARIATE ANALYSIS; VITAMIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; BONE DENSITY; CALCIFEDIOL; CALCITRIOL; CALCIUM; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERPARATHYROIDISM, PRIMARY; KIDNEY; KIDNEY FUNCTION TESTS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PHOSPHATES; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SEX FACTORS;

EID: 33845629918     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02680.x     Document Type: Article

References (53)

1. Colston, K.W., Evans, I.M., Spelsberg, T.C. & MacIntyre, I. (1977) Feedback regulation of vitamin D metabolism by 1,25-dihydroxycholecalciferol. Biochemical Journal, 164, 83-89.
2. Fraser, D.R. & Kodicek, E. (1973) Regulation of 25- hydroxycholecalciferol-1-hydroxylase activity in kidney by parathyroid hormone. Nature New Biology, 241, 163-166.
3. Henry, H.L. (2005) The 25-hydroxyvitamin D 1-hydroxylase. In: D. Feldman, J.W. Pike, F.H. Glorieux eds. Vitamin D. Elsevier Academic Press, San Diego, CA, 69-83.
4. Gray, R.W. & Napoli, J.L. (1983) Dietary phosphate deprivation increases 1,25-dihyroxyvitamin D3 synthesis in rat kidney in vitro. Journal of Biological Chemistry, 258, 1152-1155.
5. Horwitz, M.J., Tedesco, M.B., Sereika, S.M., Hollis, B.W., Garcia-Ocana, A. & Stewart, A.F. (2003) Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers. Journal of Clinical Endocrinology and Metabolism, 88, 1603-1609.
6. 2 vitamin D. Journal of Bone and Mineral Research, 20, 1792-1803.
7. Fujita, T., Inoue, T., Morii, H., Morita, R., Norimatsu, H., Orimo, H., Takahashi, H.E., Yamamoto, K. & Fukunaga, M. (1999) Effect of an intermittent weekly dose of human parathyroid hormone (1-34) on osteoporosis: a randomized double-masked prospective study using three dose levels. Osteoporosis International, 9, 296-306.
8. Lalor, B.C., Mawer, E.B., Davies, M., Lumb, G.A., Hunt, L. & Adams, P.H. (1989) Determinants of the serum concentration of 1,25-dihydroxyvitamin D in primary hyperparathyroidism. Clinical Science, 76, 81-86.
9. Mosekilde, L., Charles, P. & Lindegreen, P. (1989) Determinants for serum 1,25-dihydroxycholecalciferol in primary hyperparathyroidism. Bone and Mineral, 5, 279-290.
10. Thakker, R.V., Fraher, L.J., Adami, S., Karmali, R. & O'Riordan, J.L. (1986) Circulating concentrations of 1,25-dihydroxyvitamin D3 in patients with primary hyperparathyroidism. Bone and Mineral, 1, 137-144.
11. Frølich, A., Storm, T. & Thode, J. (1996) Does the plasma concentration of 25-hydroxyvitamin D determine the level of 1,25- dihydroxyvitamin D in primary hyperparathyroidism. Mineral and Electrolyte Metabolism, 22, 203-206.
12. Wortsman, J., Haddad, J.G., Posillico, J.T. & Brown, E.M. (1986) Primary hyperparathyroidism with low serum 1,25-dihydroxyvitamin D levels. Journal of Clinical Endocrinology and Metabolism, 62, 1305-1308.
13. Yamashita, H., Noguchi, S., Uchino, S., Watanabe, S., Murakami, T., Ogawa, T., Masatsugu, T., Takamatsu, Y., Miyatake, E. & Yamashita, H. (2003) Influence of renal function on clinico-pathological features of primary hyperparathyroidism. European Journal of Endocrinology, 148, 597-602.
14. Bilezikian, J.P., Silverberg, S.J., Shane, E., Parisien, M. & Dempster, D. J. (1991) Characterization and evaluation of asymptomatic primary hyperparathyroidism. Journal of Bone and Mineral Research, 6 (Suppl. 2), S85-S89.
15. Parfitt, A.M., Rao, D.S. & Kleerekoper, M. (1991) Asymptomatic primary hyperparathyroidism discovered by multichannel biochemical screening: clinical course and considerations bearing on the need for surgical intervention. Journal of Bone and Mineral Research, 6 (Suppl. 2), S97-S101.
16. Wermers, R.A., Khosla, S., Atkinson, E.J., Hodgson, S.F., O'Fallon, W.M. & Melton, L.J. (1997) The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Annals of Internal Medicine, 126, 433-440.
17. Bilezikian, J.P. & Silverberg, S.J. (2004) Clinical practice. Asymptomatic primary hyperparathyroidism. New England Journal of Medicine, 350, 1746-1751.
18. Moosgaard, B., Vestergaard, P., Heickendorff, L., Melsen, F., Christiansen, P. & Mosekilde, L. (2005) Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clinical Endocrinology, 63, 506-513.
19. Lumb, G.A. & Stanbury, S.W. (1974) Parathyroid function in human vitamin D deficiency and vitamin D deficiency in primary hyperparathyroidism. American Journal of Medicine, 56, 833-839.
20. Rao, D.S., Honasoge, M., Divine, G.W., Phillips, E.R., Lee, M.W., Ansari, M.R., Talpos, G.B. & Parfitt, A.M. (2000) Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications. Journal of Clinical Endocrinology and Metabolism, 85, 1054-1058.
21. Silverberg, S.J., Shane, E., Dempster, D.W. & Bilezikian, J.P. (1999) The effects of vitamin D insufficiency in patients with primary hyperparathyroidism. American Journal of Medicine, 107, 561-567.
22. Silverberg, S.J. & Bilezikian, J.P. (2001) Clinical presentation of primary hyperparathyroidism in the United States. In: J.P. Bilezikian, R. Marcus, M.A. Levine eds. The Parathyroids: Basic and Clinical Concepts. Academic Press, San Diego, CA, 349-360.
23. Grey, A., Lucas, J., Horne, A., Gamble, G., Davidson, J.S. & Reid, I.R. (2005) Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. Journal of Clinical Endocrinology and Metabolism, 90, 2122-2126.
24. Parikh, S.J., Edelman, M., Uwaifo, G.I., Freedman, R.J., Semega-Janneh, M., Reynolds, J. & Yanovski, J.A. (2004) The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. Journal of Clinical Endocrinology and Metabolism, 89, 1196-1199.
25. Snijder, M.B., van Dam, R.M., Visser, M., Deeg, D.J., Dekker, J.M., Bouter, L.M., Seidell, J.C. & Lips, P. (2005) Adiposity in relation to vitamin D status and parathyroid hormone levels: a population-based study in older men and women. Journal of Clinical Endocrinology and Metabolism, 90, 4119-4123.
26. Arunabh, S., Pollack, S., Yeh, J. & Aloia, J.F. (2003) Body fat content and 25-hydroxyvitamin D levels in healthy women. Journal of Clinical Endocrinology and Metabolism, 88, 157-161.
27. Bolland, M.J., Grey, A.B., Gamble, G.D. & Reid, I.R. (2005) Association between primary hyperparathyroidism and increased body weight: a meta-analysis. Journal of Clinical Endocrinology and Metabolism, 90, 1525-1530.
28. Grey, A. & Reid, I. (1995) Body weight and bone mineral density in hyperparathyroidism. Annals of Internal Medicine, 123, 732.
29. Souberbielle, J.C., Cormier, C., Kindermans, C., Gao, P., Cantor, T., Forette, F. & Baulieu, E.E. (2001) Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. Journal of Clinical Endocrinology and Metabolism, 86, 3086-3090.
30. Souberbielle, J.C., Lawson-Body, E., Hammadi, B., Sarfati, E., Kahan, A. & Cormier, C. (2003) The use in clinical practice of parathyroid hormone normative values established in vitamin D-sufficient subjects. Journal of Clinical Endocrinology and Metabolism, 88, 3501-3504.
31. Mollerup, C.L., Vestergaard, P., Frokjaer, V.G., Mosekilde, L., Christiansen, P. & Blichert-Toft, M. (2002) Risk of renal stone events in primary hyperparathyroidism before and after parathyroid surgery: controlled retrospective follow up study. British Medical Journal, 325, 807.
32. Patron, P., Gardin, J.P. & Paillard, M. (1987) Renal mass and reserve of vitamin D: determinants in primary hyperparathyroidism. Kidney International, 31, 1174-1180.
33. Frolich, A., Nielsen, B.F. & Transbol, I. (1990) Respective roles of 25 hydroxy-vitamin D, PTH, phosphate and renal function for the 1-alpha-hydroxylase activity in primary hyperparathyroidism. Mineral and Electrolyte Metabolism, 16, 210-215.
34. Kaplan, R.A., Haussler, M.R., Deftos, L.J., Bone, H. & Pak, C.Y. (1977) The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. Journal of Clinical Investigation, 59, 756-760.
35. Yamamoto, M., Kawanobe, Y., Takahashi, H., Shimazawa, E., Kimura, S. & Ogata, E. (1984) Vitamin D deficiency and renal calcium transport in the rat. Journal of Clinical Investigation, 74, 507-513.
36. 2D3 inhibits hormone secretion and proliferation but not functional dedifferentiation of cultured bovine parathyroid cells. Calcified Tissue International, 43, 213-218.
37. Silver, J., Russell, J. & Sherwood, L.M. (1985) Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. Proceedings of the National Academy of Sciences of the United States of America, 82, 4270-4273.
38. Broadus, A.E., Magee, J.S., Mallette, L.E., Horst, R.L., Lang, R., Jensen, P.S., Gertner, J.M. & Baron, R. (1983) A detailed evaluation of oral phosphate therapy in selected patients with primary hyperparathyoidism. Journal of Clinical Endocrinology and Metabolism, 56, 953-961.
39. Vieth, R., Bayley, A., Walfish, P.G., Rosen, I.B. & Pollard, A. (1991) Relevance of vitamin D metabolite concentrations in supporting the diagnosis of primary hyperparathyroidism. Surgery, 110, 1043-1047.
40. LoCascio, V., Adami, S., Galvanini, G., Ferrari, M., Cominacini, L. & Tartarotti, D. (1985) Substrate-product of 1-hydroxylase activity in primary hyperparathyroidism. New England Journal of Medicine, 313, 1123-1125.
41. Wortsman, J., Matsuoka, L.Y., Chen, T.C., Lu, Z. & Holick, M.F. (2000) Decreased bioavailability of vitamin D in obesity. American Journal of Clinical Nutrition, 72, 690-693.
42. McCarty, M.F. & Thomas, C.A. (2003) PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight. Medical Hypotheses, 61, 535-542.
43. Zemel, M.B. (2002) Regulation of adiposity and obesity risk by dietary calcium: mechanisms and implications. Journal of the American College of Nutrition, 21, 146S-151S.
44. van Hoof, H.J., van der Mooren, M.J., Swinkels, L.M., Rolland, R. & Benraad, T.J. (1994) Hormone replacement therapy increases serum 1,25-dihydroxyvitamin D: a 2-year prospective study. Calcified Tissue International, 55, 417-419
45. Broadus, A.E., Horst, R.L., Lang, R., Littledike, E.T. & Rasmussen, H. (1980) The importance of circulating 1,25-dihydroxyvitamin D in the pathogenesis of hypercalciuria and renal-stone formation in primary hyperparathyroidism. New England Journal of Medicine, 302, 421-426.
46. Locker, F.G., Silverberg, S.J. & Bilezikian, J.P. (1997) Optimal dietary calcium intake in primary hyperparathyroidism. American Journal of Medicine, 102, 543-550.
47. Silverberg, S.J., Shane, E., Jacobs, T.P., Siris, E.S., Gartenberg, F., Seldin, D., Clemens, T.L. & Bilezikian, J.P. (1990) Nephrolithiasis and bone involvement in primary hyperparathyroidism. American Journal of Medicine, 89, 327-334.
48. Charles, P., Mosekilde, L. & Jensen, F.T. (1986) Primary hyperparathyroidism: evaluated by 47calcium kinetics, calcium balance and serum bone-Gla-protein. European Journal of Clinical Investigation, 16, 277-283.
49. St Arnaud, R. & Glorieux, F.H. (1997) Vitamin D and bone development. In: D. Feldman, F.H. Glorieux, J.W. Pike eds. Vitamin D. Academic Press, San Diego, CA, 293-303.
50. Adams, N.D., Gray, R.W. & Lemann, J. Jr (1979) The effects of oral CaCO3 loading and dietary calcium deprivation on plasma 1,25-dihydroxyvitamin D concentrations in healthy adults. Journal of Clinical Endocrinology and Metabolism, 48, 1008-1016.
51. Prince, R.L., Wark, J.D., Omond, S., Opie, J.M., Eagle, M.R. & Eisman, J.A. (1983) A test of 1,25-dihydroxyvitamin D3 secretory capacity in normal subjects for application in metabolic bone diseases. Clinical Endocrinology, 18, 127-133.
52. Halloran, B.P., Portale, A.A., Castro, M., Morris, R.C. Jr & Goldsmith, R.S. (1985) Serum concentration of 1,25-dihydroxyvitamin D in the human: diurnal variation. Journal of Clinical Endocrinology and Metabolism, 60, 1104-1110
53. Rejnmark, L., Lauridsen, A.L., Vestergaard, P., Heickendorff, L., Andreasen, F. & Mosekilde, L. (2002) Diurnal rhythm of plasma 1,25-dihydroxyvitamin D and vitamin D-binding protein in postmenopausal women: relationship to plasma parathyroid hormone and calcium and phosphate metabolism. European Journal of Endocrinology, 146, 635-642.